Amino acids are those organic compounds that contain carboxyl (-COOH) and amine (-NH2) functional groups together with a lateral chain (R group) specific to each amino acid.
The core rudiments of an amino acid are carbon (C), oxygen (O), hydrogen (H), and nitrogen (N), though other rudiments are discovered in the side chains of some amino acids. Around 500 naturally taking place amino acids are recognized, however only 20 are visible in the genetic code, and can be segmented in countless ways.
One metabolic disorder is also associated with amino acid. Amino acids are "building blocks" that consolidate to frame proteins. In the event that one have one of these issues, the body may experience difficulty separating certain amino acids. Or on the other hand there might be an issue getting the amino acids into the cells.
These issues cause a development of destructive substances in the body. That can prompt genuine, now and again dangerous, medical issues.
These clutters are generally acquired. A child who is conceived with one might not have any indications immediately. Since the disorders can be so genuine, early analysis and treatment are basic. Infants get screened for a considerable lot of them, utilizing blood tests for bone metabolism test.
Medications may incorporate uncommon eating regimens, drugs, and supplements. A few infants may likewise require extra medicines if there are complexities.
Future Market Insights (FMI) has published a new research report on the global amino acids metabolism disorders treatment market that covers several crucial points pertaining to the growth track of the global market. Dynamics such as drivers, important trends, information about market players, restraints, strategies, product portfolio, and policies have been highlighted in the report.
The report also provides the peruser with data pertaining to the future, present, and past of the market. Data related to the regions and other segments have also been offered in the study. .
According to FMI, the global amino acid metabolism disorders treatment market is projected to rise at a stable CAGR from 2017 to 2026. The market is projected to touch a valuation of over US$1,030 Mn by the end of the forecast period
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
North America is anticipated to retain a foremost position in the market by the end of the forecast period touching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.
Players operating in this market can seek potential opportunities from the U.S., Germany, Spain, and France owing to numerous clinical trials taking place pertaining to this treatment and several mergers and acquisitions occurring among core players operating in these regions.
Players can also find lucrative opportunities from Asia Pacific excluding Japan and as well with the rise in nutritional management activities in these regions. Countries in APAC such as China and India are also anticipated to emerge as potential adopters of amino acid metabolism disorders treatment in the long run.
On the basis of sales channel, the global market for amino acid metabolism disorder treatment has been classified into hospital pharmacies, retail pharmacies, and online sales. Hospital pharmacies is expected to take the lead among all these by the end of 2026.
Based on product type, carglumic acid is expected to lead the market until the end of the forecast period reaching a valuation of over US$185 Mn. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate over the course of the forecast period.
Principal Consultant
The companies operating in the market are GlaxoSmithKline PLC, Pfizer, Inc., AMINO GmbH, Merck KGaA, Recordati S.p.A., Koninklijke DSM N.V., Sanofi, Shine Star (Hubei) Biological Engineering Co., Civentichem, LLC, Ltd., and Kyowa Hakko Kirin Co., Ltd.
Region:
Product Type:
Indication:
Sales Channel:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The amino acid metabolism disorders treatment market is anticipated to grow at 6.2% CAGR through 2032.
North America holds the biggest market space in the amino acid metabolism disorders treatment market with a valuation of over USD 359 Mn in 2022.
The amino acid metabolism disorders treatment market is estimated to surpass US$ 1.39 Bn by 2032.
The amino acid metabolism disorders treatment market size is anticipated to be over US$ 814.27 Mn in 2022.
1. Global Economic Outlook
2. Global Amino Acid Disorder Treatment Market - Executive Summary
3. Global Amino Acid Disorder Treatment Market Overview
3.1. Introduction
3.1.1. Global Amino Acid Disorder Treatment Market Taxonomy
3.1.2. Global Amino Acid Disorder Treatment Market Definition
3.2. Global Amino Acid Disorder Treatment Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Amino Acid Disorder Treatment Market Y-o-Y Growth
3.3. Global Amino Acid Disorder Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Types of Amino Acid Metabolism Disorder
3.8. Epidemiology of Amino Acid Metabolism
3.9. Patent Analysis
3.10. Investment Feasibility Index
3.11. PEST Analysis
3.12. Market Positioning & Behavior Assessment
3.13. Market Competition Structure
3.14. Key Participants Market Presence (Intensity Map) By Region
4. Global Amino Acid Disorder Treatment Market Analysis and Forecast 2012-2026
4.1. Global Amino Acid Disorder Treatment Market Size and Forecast By Product Type, 2012-2026
4.1.1. Arginine Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Folic Acid Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Vitamin B6 & B12 Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Thiamine Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Vitamin D Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Betaine Market Size and Forecast, 2012-2026
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.1.7. Carglumic Acid Market Size and Forecast, 2012-2026
4.1.7.1. Revenue (US$ Mn) Comparison, By Region
4.1.7.2. Market Share Comparison, By Region
4.1.7.3. Y-o-Y growth Comparison, By Region
4.1.8. Sapropterin Dihydrochloride Market Size and Forecast, 2012-2026
4.1.8.1. Revenue (US$ Mn) Comparison, By Region
4.1.8.2. Market Share Comparison, By Region
4.1.8.3. Y-o-Y growth Comparison, By Region
4.1.9. Others Market Size and Forecast, 2012-2026
4.1.9.1. Revenue (US$ Mn) Comparison, By Region
4.1.9.2. Market Share Comparison, By Region
4.1.9.3. Y-o-Y growth Comparison, By Region
4.2. Global Amino Acid Disorder Treatment Market Size and Forecast By Indication, 2012-2026
4.2.1. Phenylketonuria Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Maple Syrup Urine Disease Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Argininosuccinic Acidemia Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Citrullinemia Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.2.5. Homocystinuria Market Size and Forecast, 2012-2026
4.2.5.1. Revenue (US$ Mn) Comparison, By Region
4.2.5.2. Market Share Comparison, By Region
4.2.5.3. Y-o-Y growth Comparison, By Region
4.3. Global Amino Acid Disorder Treatment Market Size and Forecast By Sales Channel, 2012-2026
4.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Online Sales Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
5. North America Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type
5.6. Revenue (US$ Mn) Comparison, By Indication
5.7. Revenue (US$ Mn) Comparison, By Sales Channel
6. Latin America Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type
6.6. Revenue (US$ Mn) Comparison, By Indication
6.7. Revenue (US$ Mn) Comparison, By Sales Channel
7. Europe Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type
7.6. Revenue (US$ Mn) Comparison, By Indication
7.7. Revenue (US$ Mn) Comparison, By Sales Channel
8. Japan Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type
8.6. Revenue (US$ Mn) Comparison, By Indication
8.7. Revenue (US$ Mn) Comparison, By Sales Channel
9. APEJ Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type
9.6. Revenue (US$ Mn) Comparison, By Indication
9.7. Revenue (US$ Mn) Comparison, By Sales Channel
10. MEA Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type
10.6. Revenue (US$ Mn) Comparison, By Indication
10.7. Revenue (US$ Mn) Comparison, By Sales Channel
11. Global Amino Acid Disorder Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Company Market Share Analysis
11.2. Competitive Landscape
11.3. Company Profiles
11.3.1. Pfizer, Inc.
11.3.1.1. Overview
11.3.1.2. Offering Portfolio
11.3.1.3. Production Footprint
11.3.1.4. Sales Footprint
11.3.1.5. Channel Footprint
11.3.1.6. Strategy Outlook
11.3.1.7. Sales Strategy
11.3.1.8. Channel Strategy
11.3.1.9. Marketing Strategy
11.3.2. GlaxoSmithKline PLC
11.3.2.1. Overview
11.3.2.2. Offering Portfolio
11.3.2.3. Production Footprint
11.3.2.4. Sales Footprint
11.3.2.5. Channel Footprint
11.3.2.6. Strategy Outlook
11.3.2.7. Sales Strategy
11.3.2.8. Channel Strategy
11.3.2.9. Marketing Strategy
11.3.3. Merck KGaA
11.3.3.1. Overview
11.3.3.2. Offering Portfolio
11.3.3.3. Production Footprint
11.3.3.4. Sales Footprint
11.3.3.5. Channel Footprint
11.3.3.6. Strategy Outlook
11.3.3.7. Sales Strategy
11.3.3.8. Channel Strategy
11.3.3.9. Marketing Strategy
11.3.4. Koninklijke DSM N.V.
11.3.4.1. Overview
11.3.4.2. Offering Portfolio
11.3.4.3. Production Footprint
11.3.4.4. Sales Footprint
11.3.4.5. Channel Footprint
11.3.4.6. Strategy Outlook
11.3.4.7. Sales Strategy
11.3.4.8. Channel Strategy
11.3.4.9. Marketing Strategy
11.3.5. Recordati S.p.A.
11.3.5.1. Overview
11.3.5.2. Offering Portfolio
11.3.5.3. Production Footprint
11.3.5.4. Sales Footprint
11.3.5.5. Channel Footprint
11.3.5.6. S1trategy Outlook
11.3.5.7. Sales Strategy
11.3.5.8. Channel Strategy
11.3.5.9. Marketing Strategy
11.3.6. Sanofi
11.3.6.1. Overview
11.3.6.2. Offering Portfolio
11.3.6.3. Production Footprint
11.3.6.4. Sales Footprint
11.3.6.5. Channel Footprint
11.3.6.6. Strategy Outlook
11.3.6.7. Sales Strategy
11.3.6.8. Channel Strategy
11.3.6.9. Marketing Strategy
11.3.7. Civentichem, LLC
11.3.7.1. Overview
11.3.7.2. Offering Portfolio
11.3.7.3. Production Footprint
11.3.7.4. Sales Footprint
11.3.7.5. Channel Footprint
11.3.7.6. Strategy Outlook
11.3.7.7. Sales Strategy
11.3.7.8. Channel Strategy
11.3.7.9. Marketing Strategy
11.3.8. Shine Star (Hubei) Biological Engineering Co., Ltd.
11.3.8.1. Overview
11.3.8.2. Offering Portfolio
11.3.8.3. Production Footprint
11.3.8.4. Sales Footprint
11.3.8.5. Channel Footprint
11.3.8.6. Strategy Outlook
11.3.8.7. Sales Strategy
11.3.8.8. Channel Strategy
11.3.8.9. Marketing Strategy
11.3.9. AMINO GmbH
11.3.9.1. Overview
11.3.9.2. Offering Portfolio
11.3.9.3. Production Footprint
11.3.9.4. Sales Footprint
11.3.9.5. Channel Footprint
11.3.9.6. Strategy Outlook
11.3.9.7. Sales Strategy
11.3.9.8. Channel Strategy
11.3.9.9. Marketing Strategy
11.3.10. Kyowa Hakko Kirin Co., Ltd.
11.3.10.1. Overview
11.3.10.2. Offering Portfolio
11.3.10.3. Production Footprint
11.3.10.4. Sales Footprint
11.3.10.5. Channel Footprint
11.3.10.6. Strategy Outlook
11.3.10.7. Sales Strategy
11.3.10.8. Channel Strategy
11.3.10.9 Marketing Strategy
12. Research Methodology
13. Disclaimer
Explore Healthcare Insights
View Reports
Amino Acid Metabolism Disorders Treatment Market
